Evidence map›Paper›PMID 27245600›Full record

ArticlePediatric nephrology (Berlin, Germany)2016

Renal transplantation in Bardet-Biedl Syndrome.

Robert M Haws, Aditya Joshi, Siddharth A Shah, Omar Alkandari, Martin A Turman

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02329210 (Clinical Registry Investigating Bardet-Biedl Syndrome), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02329210 recruitingnot on this map

Clinical Registry Investigating Bardet-Biedl Syndrome

Typeobservational_patient_registrySponsorMarshfield Clinic Research FoundationRan2014 to 2030Enrolled1,200ConditionsBardet-Biedl Syndrome
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook.Therapeutics and clinical risk management · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Robert M HawsDepartment of Pediatrics, Marshfield Clinic, 1000 N Oak Ave, Marshfield, WI, 54449, USA. haws.robert@marshfieldclinic.org.
Aditya JoshiDepartment of Pediatrics, Marshfield Clinic, 1000 N Oak Ave, Marshfield, WI, 54449, USA.
Siddharth A ShahDepartment of Pediatrics, University of Louisville, Louisville, KY, USA.
Omar AlkandariDepartment of Pediatrics, Mubarak Al-Kabeer Hospital & Hamid Al-Essa Transplant Center, Safat, Kuwait.
Martin A TurmanDepartment of Pediatric Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Marshfield Clinic · USMubarak Al Kabeer Hospital · KWUniversity of Louisville · USUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal anomalies are common in patients with Bardet-Biedl syndrome (BBS), a renal cystic ciliopathy with multi-systemic features. Renal transplantation is indicated in cases of end-stage renal disease (ESRD), but transplant centers may be hesitant to perform the necessary transplant in light of the multitude of metabolic comorbidities these patients often face with the potential to complicate outcomes.

methodsData from the Clinical Registry Investigating BBS (CRIBBS) were used to investigate renal transplant outcomes in the largest BBS cohort described to date.

resultsOf the 206 patients enrolled in the CRIBBS, 21 children (10.2 %; 16 girls, 5 boys; median age 8.4 years) had been diagnosed with ESRD. Renal transplantation was performed in 18 of these individuals between 1982 and 2015, including repeat transplantation in some cases, for a total of 22 kidneys. Overall graft survival was 81.6 % at 1 year post-transplantation, 75.7 % at 5 years, 59 % at 10 years, and 49.2 % at 25 years. Patient survival was 94.4 % at 1 year post-transplantation, 87.2 % at 8 years, and 79.3 % at 25 years.

conclusionsAt a median follow-up time of 97 months, relatively few complications of renal transplantation were reported in the patients of this study. However, body mass index was significantly elevated in transplanted individuals compared to non-transplanted individuals participating in CRIBBS at the most recent follow-up. Although the frequency of obesity and other manifestations of the metabolic syndrome warrant meticulous management in this high-risk population, favorable long-term outcomes suggest that renal transplantation is a viable option for patients with BBS and ESRD.

Indexed as

AdolescentAdultAge FactorsBardet-Biedl SyndromeBody Mass IndexChildChild, PreschoolComorbidityFemaleFollow-Up StudiesGraft SurvivalHumansKaplan-Meier EstimateKidney Failure, ChronicKidney TransplantationMaleBardet–Biedl SyndromeCiliopathyEnd-stage renal diseaseGraftRenal transplantSurvival

Identifiers

PMID27245600
OpenAlexW2409694441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.